Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Pathology, Alexandria University, Alexandria, Egypt.
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
J Thorac Oncol. 2019 Sep;14(9):1583-1593. doi: 10.1016/j.jtho.2019.05.009. Epub 2019 May 20.
Tumor spread through air spaces (STAS) has prognostic significance in lung adenocarcinoma and squamous cell carcinoma. We sought to investigate the prognostic importance of STAS in lung neuroendocrine tumors (NETs).
All tumor slides from patients with resected pathologic stage I to III lung NETs (N = 487) (299 with typical carcinoid [TC], 38 with atypical carcinoid [AC], 93 with large cell neuroendocrine carcinoma [LCNEC], and 57 with SCLC) treated between 1992 and 2012 were evaluated for presence of STAS. Cumulative incidence of recurrence (CIR) and lung cancer-specific cumulative incidence of death (LC-CID) were analyzed by using a competing-risks approach.
STAS was identified in 26% of NETs (16% of TCs, 37% of ACs, 43% of LCNECs, and 46% of SCLCs). STAS was associated with distant metastasis, as well as with higher CIR and LC-CID in the overall cohort and in the AC, LCNEC, and SCLC cohorts (owing to a small number of recurrences and deaths [<5], prognostic analysis was not performed in the TC cohort). In multivariable analysis stratified by stage, STAS was significantly associated with higher CIR (subhazard ratio = 2.85, 95% confidence interval: 1.73-4.68, p < 0.001) and LC-CID (subhazard ratio = 2.72, 95% confidence interval: 1.57-4.70, p < 0.001), independent of histologic subtype. STAS was independently associated with CIR and LC-CID in the LCNEC cohort and LC-CID in the SCLC cohort.
In patients with lung NETs, STAS is associated with early distant metastasis and worse LC-CID. In patients with LCNEC or SCLC, STAS is an independent poor prognostic factor.
在肺腺癌和鳞状细胞癌中,肿瘤通过气腔播散(STAS)具有预后意义。我们试图研究 STAS 在肺神经内分泌肿瘤(NETs)中的预后重要性。
评估了 1992 年至 2012 年间治疗的病理分期 I 至 III 期肺 NETs(N=487)(299 例典型类癌[TC],38 例非典型类癌[AC],93 例大细胞神经内分泌癌[LCNEC]和 57 例小细胞肺癌[SCLC])所有肿瘤切片中是否存在 STAS。使用竞争风险方法分析复发累积发生率(CIR)和肺癌特异性死亡累积发生率(LC-CID)。
NETs 中发现 STAS 占 26%(TC 为 16%,AC 为 37%,LCNEC 为 43%,SCLC 为 46%)。STAS 与远处转移以及在整个队列以及 AC、LCNEC 和 SCLC 队列中的更高 CIR 和 LC-CID 相关(由于复发和死亡的数量较少[<5],因此在 TC 队列中未进行预后分析)。在按分期分层的多变量分析中,STAS 与更高的 CIR(亚危险比=2.85,95%置信区间:1.73-4.68,p<0.001)和 LC-CID(亚危险比=2.72,95%置信区间:1.57-4.70,p<0.001)显著相关,独立于组织学亚型。STAS 与 LCNEC 队列中的 CIR 和 LC-CID 以及 SCLC 队列中的 LC-CID 独立相关。
在肺 NETs 患者中,STAS 与早期远处转移和更差的 LC-CID 相关。在 LCNEC 或 SCLC 患者中,STAS 是独立的不良预后因素。